Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly’s weight-loss drug Zepbound and its diabetes drug Mounjaro.
Related Posts
Asia-Pacific markets mixed as Trump softens trade stance against China
South Korea’s GDP contracted 0.1% in the first quarter of 2025, according to advance figures, missing the 0.1% rise expected by Reuters’ poll.
Shipping insurance costs spike in the Middle East as Israel-Iran conflict rages
The scramble to reassess shipping insurance costs reflects the deteriorating security environment in the Middle East.
Los Angeles wildfire death toll surges to 24 as firefighters brace for more fierce winds
The death toll surged late Sunday with an update from the Los Angeles County medical examiner. At least 16 people were missing.